3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Giant Cell Tumor of Bone
2
Breast Neoplasms
2
Thyroid Cancer Metastatic
1
Osteoporotic Fractures
1
Osteoporosis
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Osteoblastoma
1
Neoplasm Metastasis
1
Musculoskeletal Pain
1
Melanoma
1
Kidney Neoplasms
1
Granuloma, Giant Cell
1
Chondroblastoma
1
Carcinoma, Renal Cell
1
Bone Metastasis From Solid Tumors
1
Bone Metastases From Solid Tumors
1
Bone Metastases
1
Bone Cysts, Aneurysmal
1
Arthralgia
1
Interventions
lenvatinib
1
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Thyroid Cancer Metastatic
×
Denosumab
×
Clear all
NCT03732495
2022-03-29
LENVOS
Centre Leon Berard
Phase 2
Unknown
35 enrolled